← Back to all signals
RESEARCH PAPER ANALYSIS

Targeted Therapies in Infantile Hemangiomas and Vascular Malformations: From β-Blockers to PI3K/AKT/mTOR Inhibitors.

AI interpretation is pending for this paper.

Open original publication →
PMID41928438
JournalJournal of cellular and molecular medicine
Publication Date2026-04-01
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Vascular tumours and malformations encompass infantile hemangiomas (IHs) and genetically driven vascular malformations with distinct natural histories and therapeutic vulnerabilities. The discovery that the non-selective beta-blocker propranolol induces rapid regression of proliferating IHs established the first widely adopted systemic pharmacologic therapy in vascular anomaly care and provided a clinical proof-of-concept that targeting lesion-specific endothelial biology can alter disease course. In parallel, recurrent somatic variants affecting PI3K/AKT/mTOR (e.g., PIK3CA, TEK/TIE2, AKT1) and RAS/MAPK (e.g., KRAS, NRAS) signalling have reframed many malformations as mosaic disorders amenable to targeted inhibition with agents such as sirolimus, alpelisib, AKT inhibitors and MEK inhibitors. This review synthesizes translational mechanisms, clinical evidence and safety considerations for beta-blockers and emerging targeted therapies, emphasizing lesion phenotype, timing of intervention and molecular stratification as determinants of response. We highlight current limitations, including toxicity, durability and pathway escape, and outline future directions for precision therapy and genotype-guided trial design in vascular anomalies.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Impact of Transport Media on IL-33 Levels in Samples From Patients With Viral Respiratory Infections. Journal of immunology research 58.2 2 Eosinophilic Fasciitis in Children: A Case Report. Cureus 51.4 3 Sporadic Burkitt Lymphoma Presenting as Refractory Iron-Deficiency Anemia in a Three-Year-Old Boy: A Case Report. Cureus 49.52 4 Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia. Nature communications 61.2 5 Postoperative antibiotic continuation does not reduce infectious complications after elective pediatric ostomy reversal: A NSQIP Pediatric analysis. Journal of pediatric surgery 68.5 6 A Phase Ib Case Series Using Bortezomib With Chemotherapy in Atypical Teratoid/Rhabdoid Tumors. Cancer medicine 84.54 7 Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation. Frontiers in molecular biosciences 86.25 8 Pembrolizumab-induced type-1 diabetes mellitus: clinical characteristics, therapeutic strategies, and prognosis from a retrospective analysis of 43 published cases. Frontiers in endocrinology 65.74 9 Feeding and swallowing function and dysphagia risk in children with posterior fossa tumors: a preliminary Italian cohort study. Frontiers in oncology 67.0 10 The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov. Frontiers in pediatrics 73.16 11 Lipidomic analysis of isolated lipid droplets reveals potential metabolic pathway differences between medulloblastoma subgroups. Frontiers in neuroscience 56.0 12 Case Report: Selumetinib as a neoadjuvant treatment for the removal of a PN. Frontiers in pediatrics 50.74 13 PACSIN2 regulates mercaptopurine cytotoxicity and cellular biomechanics through Rac1 modulation in intestinal epithelial cells. Frontiers in pharmacology 58.42 14 Enhancing Communication and Consent Using 3-D Printed Models With a Pediatric Dental Patient Presenting With Odontogenic Keratocysts Associated With Gorlin Syndrome: A Case Report. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 47.5 15 Respiratory Syncytial Virus-Associated Disease in Children Receiving Intensive Care. JAMA network open 64.5 16 A comprehensive survey of genetic variants in neuroblastoma. Journal, genetic engineering & biotechnology 59.9 17 The role of CHAMP1 in chromatin-mediated DNA damage repair. DNA repair 60.6 18 Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 64.72 19 Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway. Developmental medicine and child neurology 62.0 20 Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort. Journal of the National Cancer Institute 59.9 21 Prolonged Headache in a 13-Year-Old Girl With Acute Lymphoblastic Leukemia: A Case of Possible Neuroinflammatory Complication Responsive to Intravenous Immunoglobulin. Clinical case reports 47.8 22 Assessment of Potentially Toxic and Essential Metals in Commonly Consumed Tomato Ketchup Brands from Local Markets in Faisalabad, Pakistan, and Associated Health Risks. Biological trace element research 57.5 23 MRI-based radiomics for prognosis of non-midline, pediatric high-grade gliomas. Journal of neuro-oncology 81.0 24 Mapping an Overlooked Spiral of Trauma-Exposure to Sexual Abuse and Psycho-Spiritual Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis. Cancer nursing 79.0 25 Establishing the First National Fanconi Anemia Registry in Iran: Clinical and Epidemiological Insights From 116 Patients. Pediatric blood & cancer 61.5 26 New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline". Expert opinion on pharmacotherapy 69.1 27 Infection profile and risk factors for adverse outcomes in children with febrile neutropenia: a single-center study from Northwestern India. Pediatric hematology and oncology 62.0 28 Cryptic PML::RARA With Concurrent RUNX1::RUNX1T1 in an Adolescent With Acute Promyelocytic Leukemia. Pediatric blood & cancer 47.5 29 Body Composition and Physical Activity are Associated With Prediabetes in Childhood, Adolescent, and Young Adult Cancer and Hematopoietic Cell Transplantation Survivors. Pediatric blood & cancer 54.0 30 Early Palliative Care Is Feasible and Acceptable in Pediatric Neuro-Oncology. Pediatric blood & cancer 58.7 31 Transverse Myelitis and Guillain-Barré Syndrome in Pediatric Lymphoid Malignancies: An International Retrospective Study. Pediatric blood & cancer 65.1 32 Cost-Effectiveness of Early Empirical Antibiotic Cessation in Pediatric High-Risk Febrile Neutropenia. Pediatric blood & cancer 62.9
PATIENT-FRIENDLY SUMMARY

Targeted Therapies in Infantile Hemangiomas and Vascular Malformations: From β-Blockers to PI3K/AKT/mTOR Inhibitors.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic